{
    "eid": "2-s2.0-84949115317",
    "title": "Evidence for orexinergic mechanisms in migraine",
    "cover-date": "2015-02-01",
    "subject-areas": [
        {
            "$": "Neurology",
            "@code": "2808"
        }
    ],
    "keywords": [
        "Dual orexin receptor antagonists",
        "Headache",
        "Migraine",
        "Orexin",
        "Sleep"
    ],
    "authors": [
        "Jan Hoffmann"
    ],
    "citedby-count": 75,
    "ref-count": 58,
    "ref-list": [
        "Topiramate inhibits cortical spreading depression in rat and cat: Impact in migraine aura",
        "Diencephalic and brainstem mechanisms in migraine",
        null,
        "Insomnia and circadian variation of attacks in episodic migraine",
        "Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area",
        "Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: A Fos study",
        "Animal models of migraine: Looking at the component parts of a complex disorder",
        "Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior",
        "Neurons of the dopaminergic/calcitonin gene-related peptide A11 cell group modulate neuronal firing in the trigeminocervical complex: An electrophysiological and immunohistochemical study",
        "Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation",
        "Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties",
        "Discovery of the dual orexin receptor antagonist [(7 R)-4-(5-chloro-1,3- benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2 H -1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia",
        "Increased frequency of migraine in narcoleptic patients",
        "Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems",
        "The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity",
        "Hypothalamic activation in spontaneous migraine attacks",
        "Posterior cerebral hypoperfusion in migraine without aura",
        "The orexin/hypocretin system: A critical regulator of neuroendocrine and autonomic function",
        "Discovering Statistics Using SPSS for Windows",
        "Hypocretin (orexin) pathway to sleep",
        "Premonitory symptoms in migraine: An electronic diary study",
        "Pathophysiology of Migraine",
        "Current practice and future directions in the prevention and acute management of migraine",
        "Migraine - Current understanding and treatment",
        "Orexin receptors as therapeutic drug targets",
        "International union of basic and clinical pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacology",
        "Orexin A activates locus coeruleus cell firing and increases arousal in the rat",
        "Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant",
        "Neurology",
        "The hypothalamic orexinergic system: Pain and primary headaches",
        "Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception",
        "Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat",
        "Ann. Neurol.",
        "Acid-sensing ion channel 1: A novel therapeutic target for migraine with aura",
        "Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle",
        "Migraine diagnosis and treatment: Results from the American migraine study II",
        "Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks",
        "Differential expression of Orexin receptors 1 and 2 in the rat brain",
        "Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010",
        "Distribution of orexin neurons in the adult rat brain",
        null,
        "Neurons containing hypocretin (orexin) project to multiple neuronal systems",
        "A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains",
        "Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle",
        "Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches",
        "Reverse pharmacology of orexin: From an orphan GPCR to integrative physiology",
        "Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior",
        "Non-sleep effects of hypocretin/orexin",
        "Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: Findings from cerebrospinal fluid",
        "Orexin receptors: Pharmacology and therapeutic opportunities",
        "Narcolepsy: A key role for hypocretins (Orexins)",
        "Hypocretin (OREXIN): Role in normal behavior and neuropathology",
        "The physiology and pharmacology of the orexins",
        "Cortical hyperexcitability and mechanism of medication-overuse headache",
        "Cephalalgia",
        "Hypothalamic hypocretin (orexin): Robust innervation of the spinal cord",
        "Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat",
        "Prospective analysis of factors related to migraine attacks: The PAMINA study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Berlin",
            "affilname": "Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "San Francisco",
            "affilname": "University of California, San Francisco",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "London",
            "affilname": "Wellcome Trust",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "London",
            "affilname": "Imperial College London",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Rahway",
            "affilname": "Merck &amp; Co., Inc.",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Deutsche Forschungsgemeinschaft"
    ]
}